- Home
- LGCB vs VRAX Comparison
LGCB vs VRAX Comparison
Compare LGCB & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGCB
- VRAX
- Stock Information
- Founded
- LGCB 2011
- VRAX 2013
- Country
- LGCB Japan
- VRAX United Kingdom
- Employees
- LGCB N/A
- VRAX N/A
- Industry
- LGCB
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- LGCB
- VRAX Health Care
- Exchange
- LGCB Nasdaq
- VRAX Nasdaq
- Market Cap
- LGCB 14.8M
- VRAX 4.7M
- IPO Year
- LGCB 2023
- VRAX 2022
- Fundamental
- Price
- LGCB N/A
- VRAX $0.85
- Analyst Decision
- LGCB
- VRAX Strong Buy
- Analyst Count
- LGCB 0
- VRAX 1
- Target Price
- LGCB N/A
- VRAX $3.00
- AVG Volume (30 Days)
- LGCB 8.8K
- VRAX 37.2K
- Earning Date
- LGCB 07-03-2025
- VRAX 02-05-2025
- Dividend Yield
- LGCB N/A
- VRAX N/A
- EPS Growth
- LGCB N/A
- VRAX N/A
- EPS
- LGCB N/A
- VRAX N/A
- Revenue
- LGCB $10,289,681.00
- VRAX $6,331.00
- Revenue This Year
- LGCB N/A
- VRAX $5,169.18
- Revenue Next Year
- LGCB N/A
- VRAX $66.97
- P/E Ratio
- LGCB N/A
- VRAX N/A
- Revenue Growth
- LGCB N/A
- VRAX 7.03
- 52 Week Low
- LGCB $1.22
- VRAX $0.74
- 52 Week High
- LGCB $57.05
- VRAX $9.00
- Technical
- Relative Strength Index (RSI)
- LGCB 55.57
- VRAX 45.02
- Support Level
- LGCB $2.20
- VRAX $0.74
- Resistance Level
- LGCB $2.53
- VRAX $0.88
- Average True Range (ATR)
- LGCB 0.16
- VRAX 0.07
- MACD
- LGCB -0.00
- VRAX 0.01
- Stochastic Oscillator
- LGCB 70.95
- VRAX 50.23
About LGCB Linkage Global Inc
Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The Company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.